About this trial
Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to identify People at Risk or already Infected with HIV and HCV
Eligibility criteria
Qualifiers
None
Disqualifiers
Having already been included in the study, not signing the consent.
Trial design
Treatments tested in this trial
- rapid HIV and HCV serological tests
Treatment groups
240,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Collaborator
European Union
Collaborator
Source ClinicalTrials.gov